About Us
About Us
Ruffena Capital is a leading mid-market boutique corporate finance house advising and raising growth and transitional capital for exceptional, privately held enterprises.
Our firm is owned and run by our Partners, who have all had extensive experience in a diverse range of industries as well as private equity and private lending transactions.
Ruffena Capital Ltd is an Appointed Representative of Ashberg Limited. Ashberg provides all regulatory functions on behalf of Ruffena Capital Ltd. Ashberg Limited is authorised and regulated by the Financial Conduct Authority.
Our team has over 200 years experience between them in corporate finance, commercial strategy and running and growing businesses of all sizes and stages.
After his first degree, Robin went to Cranfield School of Management before starting in business, where he led growth in a number of businesses at a senior level, principally in technology and media including two he founded. He is today a highly versatile, commercially experienced strategy and investment professional with international experience. His clarity as founding entrepreneur, investor and professional advisor is invaluable in advising others and was instrumental in founding Ruffena Capital.
Simon has twenty years management experience in sales and marketing of technology products in various technical sectors. He is a graduate in Engineering Science and has experience in defence systems development. Simon leads the Life Sciences team and investor relations at Ruffena Capital. He has been involved in a range of successful Healthtech related fund raisings some of which have progressed to flotations or trade sales, as well as other technology related sectors.
Xavier has an extensive background in the UK, Europe, and USA Commercial Property markets. He was joint founder of Capital & Regional PLC and a main board Director for over 30 years during which time assets grew to over £5 billion. Xavier was also a joint-founder of a commercial publishing and poster advertising company including Primesight. He has experience as a Non-Executive Director and Adviser of a number of Companies and Funds.
Maarten is an experienced international finance professional, having worked in multiple roles from Netherlands to the UK, Central & Eastern Europe and the Far East.
In recent years he has focused on Fintech opportunities and since early 2018, Maarten runs the European office for Ruffena Capital.
Dwight was MD of John Govett before becoming an independent director and advisor to many start-ups, and smaller companies. He has also worked on the board of a number of quoted companies and is a key relationship builder between investors and investees. Dwight has a wealth of experience in business, business planning and in the funding of small and medium sized companies.
Shelley’s corporate experience spans management consulting, food and beverage, and paper manufacturing. Following a corporate career, she founded the Paris/London chapters of Keiretsu Forum, a global business angel/PE group. Shelley has held Director positions on the Boards of the Boston and Pacific Stock Exchanges in the US, as well as advisory roles on pan-European financial services initiatives. She has an MSc in biochemical engineering from UCL and an MBA in finance from Fordham University.
Ezgi joined Ruffena in late 2018. She previously worked as an equity research analyst at Goldman Sachs, Dubai, covering Turkish non-financial equities in consumer cyclical, industrial and retail sectors and also worked as an investment analyst at Athene Capital, London with a special focus on consumer-tech businesses.
After his first degree, Robin went to Cranfield School of Management before starting in business, where he led growth in a number of businesses at a senior level, principally in technology and media including two he founded. He is today a highly versatile, commercially experienced strategy and investment professional with international experience. His clarity as founding entrepreneur, investor and professional advisor is invaluable in advising others and was instrumental in founding Ruffena Capital.
Simon has twenty years management experience in sales and marketing of technology products in various technical sectors. He is a graduate in Engineering Science and has experience in defence systems development. Simon leads the Life Sciences team and investor relations at Ruffena Capital. He has been involved in a range of successful Healthtech related fund raisings some of which have progressed to flotations or trade sales, as well as other technology related sectors.
Xavier has an extensive background in the UK, Europe, and USA Commercial Property markets. He was joint founder of Capital & Regional PLC and a main board Director for over 30 years during which time assets grew to over £5 billion. Xavier was also a joint-founder of a commercial publishing and poster advertising company including Primesight. He has experience as a Non-Executive Director and Adviser of a number of Companies and Funds.
Maarten is an experienced international finance professional, having worked in multiple roles from Netherlands to the UK, Central & Eastern Europe and the Far East.
In recent years he has focused on Fintech opportunities and since early 2018, Maarten runs the European office for Ruffena Capital.
Dwight was MD of John Govett before becoming an independent director and advisor to many start-ups, and smaller companies. He has also worked on the board of a number of quoted companies and is a key relationship builder between investors and investees. Dwight has a wealth of experience in business, business planning and in the funding of small and medium sized companies.
Patrick has many years experience in funding young rapidly growing unquoted businesses with equity and near equity financing. He has advised companies, in a variety of sectors, on equity funding through all stages of the funding process. Educated at Oxford with an MPhil in Management and at Reading with a BSc in Agriculture, Patrick also has experience of business both in the UK and in the developing world.
Shelley’s corporate experience spans management consulting, food and beverage, and paper manufacturing. Following a corporate career, she founded the Paris/London chapters of Keiretsu Forum, a global business angel/PE group. Shelley has held Director positions on the Boards of the Boston and Pacific Stock Exchanges in the US, as well as advisory roles on pan-European financial services initiatives. She has an MSc in biochemical engineering from UCL and an MBA in finance from Fordham University.
Ezgi joined Ruffena in late 2018. She previously worked as an equity research analyst at Goldman Sachs, Dubai, covering Turkish non-financial equities in consumer cyclical, industrial and retail sectors and also worked as an investment analyst at Athene Capital, London with a special focus on consumer-tech businesses.
After his first degree, Robin went to Cranfield School of Management before starting in business, where he led growth in a number of businesses at a senior level, principally in technology and media including two he founded. He is today a highly versatile, commercially experienced strategy and investment professional with international experience. His clarity as founding entrepreneur, investor and professional advisor is invaluable in advising others and was instrumental in founding Ruffena Capital.
Simon has twenty years management experience in sales and marketing of technology products in various technical sectors. He is a graduate in Engineering Science and has experience in defence systems development. Simon leads the Life Sciences team and investor relations at Ruffena Capital. He has been involved in a range of successful Healthtech related fund raisings some of which have progressed to flotations or trade sales, as well as other technology related sectors.
Xavier has an extensive background in the UK, Europe, and USA Commercial Property markets. He was joint founder of Capital & Regional PLC and a main board Director for over 30 years during which time assets grew to over £5 billion. Xavier was also a joint-founder of a commercial publishing and poster advertising company including Primesight. He has experience as a Non-Executive Director and Adviser of a number of Companies and Funds.
Maarten is an experienced international finance professional, having worked in multiple roles from Netherlands to the UK, Central & Eastern Europe and the Far East.
In recent years he has focused on Fintech opportunities and since early 2018, Maarten runs the European office for Ruffena Capital.
Dwight was MD of John Govett before becoming an independent director and advisor to many start-ups, and smaller companies. He has also worked on the board of a number of quoted companies and is a key relationship builder between investors and investees. Dwight has a wealth of experience in business, business planning and in the funding of small and medium sized companies.
Patrick has many years experience in funding young rapidly growing unquoted businesses with equity and near equity financing. He has advised companies, in a variety of sectors, on equity funding through all stages of the funding process. Educated at Oxford with an MPhil in Management and at Reading with a BSc in Agriculture, Patrick also has experience of business both in the UK and in the developing world.
Shelley’s corporate experience spans management consulting, food and beverage, and paper manufacturing. Following a corporate career, she founded the Paris/London chapters of Keiretsu Forum, a global business angel/PE group. Shelley has held Director positions on the Boards of the Boston and Pacific Stock Exchanges in the US, as well as advisory roles on pan-European financial services initiatives. She has an MSc in biochemical engineering from UCL and an MBA in finance from Fordham University.
Ezgi joined Ruffena in late 2018. She previously worked as an equity research analyst at Goldman Sachs, Dubai, covering Turkish non-financial equities in consumer cyclical, industrial and retail sectors and also worked as an investment analyst at Athene Capital, London with a special focus on consumer-tech businesses.
Experience, professionalism and rigour in every transaction
Ruffena Capital Ltd is an Appointed Representative of Ashberg Limited. Ashberg provides all regulatory functions on behalf of Ruffena Capital Ltd. Ashberg Limited is authorised and regulated by the Financial Conduct Authority.
